GlaxoSmithKline's total assets for Q4 2022 were £60.15B, a decrease of -0.28% from the previous quarter. GB:GSK total liabilities were £50.05B for the fiscal quarter, a -3.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.